Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|23|34|5173-5179
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.23, Iss.34, 2018-01, pp. : 5173-5179
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Biologic Therapy for Inflammatory Bowel Disease
By Ardizzone Sandro Gabriele Bianchi Porro
Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. :
Access to resources
Recommend
Current Therapy of Inflammatory Bowel Disease in Children
By Rufo Paul A. Bousvaros Athos
Pediatric Drugs, Vol. 8, Iss. 5, 2006-01 ,pp. :
Infliximab Therapy in Children and Adolescents with Inflammatory Bowel Disease
By Veres Gabor
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Pharmacogenetics of Therapy in Inflammatory Bowel Disease Patients
Current Pharmacogenomics, Vol. 5, Iss. 3, 2007-09 ,pp. :
Recent developments in inflammatory bowel disease therapy
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. :